Overview
Dai-ichi Life is one of Japan's top insurance entities. Through subsidiaries, the firm specializes in individual and group life insurance, annuities, and supplemental medical coverage, as well as individual and group pension products. Dai-ichi Life also provides non-life (property/casualty) insurance products through its partnership with Sompo Japan Insurance, as well as cancer insurance through a partnership with Aflac. Other services include asset
...
Read More management and risk management. Dai-ichi Life sells its products through its network of approximately 44,000 sales staffs. The company's largest market is its home country, Japan.
Read Less
Read More management and risk management. Dai-ichi Life sells its products through its network of approximately 44,000 sales staffs. The company's largest market is its home country, Japan.
Read Less
TETSUYA KIKUTA
See more contacts
Management of Companies and Enterprises
,
Holding companies, nec
?
?
Actual
$69.69 billion
Actual
24.68%
84.63%
$67.54 million
MAR
?
?
Tokyo:8750
Contacts
Get in Touch with 15 Principals*
-
TETSUYA KIKUTAPresident
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of March 31, 2024 (12 month period) in USD
Annual Revenue 2024
$69.69 billion
USD
Actual
1 USD = 150.4891 JPY
All financial statement data is in millions except per share data | Source: Morningstar
Cash Flow (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Net Operating Cash | $6,628 | -$880 | -$3,070 |
Net Investing Cash | -$3,998 | $2,063 | $6,401 |
Net Financing Cash | -$969 | -$2,163 | -$1,201 |
Net Change in Cash | $1,661 | -$980 | $2,130 |
Cash at Beginning of Period | $16,727 | $17,388 | $15,037 |
Cash at End of Period | $18,422 | $16,727 | $17,388 |
Capital Expenditure | -$619 | -$1,074 | -$990 |
Assets (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Current Assets | |||
Cash and Cash Equivalents | $13,718 | $10,759 | $14,512 |
Accounts Receivable | $12,314 | $10,791 | $12,791 |
Inventories | $ | $ | $ |
Other Current Assets | $ | $ | $ |
Asset Summary | |||
Total Current Assets | $ | $ | $ |
Tangible Fixed Assets | $8,137 | $8,239 | $7,706 |
Intangible Assets | $3,942 | $4,116 | $2,967 |
Total Assets | $67,540,309 | $61,653,699 | $65,881,161 |
Liabilities (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Current Liabilities | |||
Accounts Payable | $3,166 | $3,882 | $5,948 |
Short-Term Debt | $ | $ | $ |
Other Current Liabilities | $ | $ | $ |
Liability Summary | |||
Total Current Liabilities | $ | $ | $ |
Long-Term Debt | $6,481 | $6,311 | $5,784 |
Other Long-Term Liabilities | $ | $ | $ |
Total Liabilities | $423,008 | $392,001 | $408,486 |
Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
---|---|---|---|
Equity | |||
Common Stock | $2,287 | $2,286 | $2,285 |
Retained Earnings | $8,071 | $7,265 | $8,870 |
Equity Summary | |||
Total Equity | $25,797 | $17,687 | $29,295 |
Shares Outstanding | 3,780,688,584 | 3,932,755,816 | 4,097,850,800 |